Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Gloria Shock

My two cents:

The upgrade to CDX4 (which I have in recent months commented should be in the works, meaning software progression is expected for competitive reasons, and begets newer, "better" versions, in theory) begs the question: What does this upgrade to CDX4 contain?

Is this version indeed better? Does it provide a smoother, more timely implementation method? Does it provide a more user-friendly GUI? Is it more powerful than previous versions regarding schema mapping?

These, and others, are questions for which answers would be greatly beneficial in assessing the future of the product, in my opinion. But, we have yet to acquire the answers. Perhaps a new specification will soon be posted to the PDSG website for our review.

Cheers,

DG

Share
New Message
Please login to post a reply